Document is current
Any future updates will be listed below
-
Authors
Devine, Jaime K. https://orcid.org/0000-0001-5016-6963
Schwartz, Lindsay https://orcid.org/0000-0002-5206-4642
Hursh, Steven https://orcid.org/0000-0002-5391-2842
Asin, Jerryll https://orcid.org/0000-0002-9573-9478
de Vries, Nicolaas
Vonk, Patty E. https://orcid.org/0000-0002-6388-3037
Vermeeren, Annemiek https://orcid.org/0000-0002-9504-1184
Donjacour, Claire E. H. M. https://orcid.org/0000-0002-9065-5574
Vinckenbosch, Frederick https://orcid.org/0000-0002-1767-7742
Ramaekers, Johannes G. https://orcid.org/0000-0003-4553-376X
Janssen, Hennie https://orcid.org/0000-0001-6868-1138
Wang, Grace
Chen, Dan
Carter, Lawrence P.
Overeem, Sebastiaan https://orcid.org/0000-0002-6445-9836
Lammers, Gert Jan https://orcid.org/0000-0003-4755-7060
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02806895 at ClinicalTrials.govnct02806908 at ClinicalTrials.govDocuments that mention this clinical trial
Psychomotor Vigilance Performance in Participants with Excessive Daytime Sleepiness in Obstructive Sleep Apnea or Narcolepsy Compared with SAFTE-FAST Model Predictions
https://doi.org/10.1007/s40120-022-00425-w
Documents that mention this clinical trial
Psychomotor Vigilance Performance in Participants with Excessive Daytime Sleepiness in Obstructive Sleep Apnea or Narcolepsy Compared with SAFTE-FAST Model Predictions
https://doi.org/10.1007/s40120-022-00425-w
-
Funding
Funding for this research was provided by:
Jazz Pharmaceuticals
Axsome Therapeutics
- License Information
-
More Information
Article History
Received: 29 July 2022
Accepted: 9 November 2022
First Online: 10 December 2022
